This observational study examines platelet activation markers in antiphospholipid syndrome, suggesting the need for further evaluation.
Although we observed raised sCLEC-2 and sCLEC-2/D-dimer ratio among APS and non-APS groups and modest differences between the two groups, clinical interpretation of the findings requires a prospective study evaluating dynamic changes of sCLEC-2 in the clinical course.
No takes yet. Share an insight, caveat, or question.
Kaneshige et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: